RARE PHARMA-GRADE BARIUM SULFATE AND IODINE IN NORTH AMERICA
- Voyageur Pharmaceuticals Ltd. (VM: TSX-V, OTC: VVYRF, Forum) is developing its 100% owned high grade barium sulfate project in BC, Canada.
- VM business plan is to develop its advanced stage pharmaceutical grade barium sulfate project, Frances Creek. Voyageur is developing barium contrast radiographic suspension products for the pharmaceutical industry.
- Frances Creek bulk sample tentatively scheduled for Q3, 2021
- VM’s pharmaceutical grade barite is naturally occurring with grades as high as 99.26% BaSO4 in-situ, which is very rare.
- Voyageur has achieved a 98.6% BaSO4 product with SGS Minerals. The only barite sold in the market place, grading +98%, is man made in a lab using an expensive manufacturing processing.
- The only other source of natural pharmaceutical grade barite is from China.
- China only exports 5% of their production of pharmaceutical barite, allocating 95% for their domestic market.
- The pharmaceutical industry primarily uses expensive man made barium sulfate for the radiographic market.
Dave Jackson Presents Voyageur Pharmaceuticals- Health Canada Licences
https://stockhouse.com/opinion/interviews/2021/02/25/health-canada-approvals-set-stage-for-revenue-generation
Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product License for SmoothX; Radiographic Barium Contrast Suspension
Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance [...]